Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of the Effectiveness of EMG-Biofeedback and Rebound Therapy in Patients With Endometriosis

NCT06517654 is registered in ClinicalTrials.gov with Medipol University as lead sponsor.

NCT NCT06517654
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06517654 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of the Effectiveness of EMG-Biofeedback and Rebound Therapy in Patients With Endometriosis
Lead sponsor
Medipol University
Phase
Not applicable
Overall status
Completed
Start date
September 1, 2024
Completion date
November 1, 2025
Enrollment
42 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endometriosis